Neutrophil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis


Creative Commons License

Çelikbilek M., Dogan S., ÖZBAKIR Ö., ZARARSIZ G., Küçük H., GÜRSOY Ş., ...Daha Fazla

JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.27, sa.1, ss.72-76, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1002/jcla.21564
  • Dergi Adı: JOURNAL OF CLINICAL LABORATORY ANALYSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.72-76
  • Anahtar Kelimeler: Neutrophil-to-lymphocyte ratio, ulcerative colitis, noninvasive monitoring, THERAPY, MANAGEMENT, MARKERS, CANCER, COHORT
  • Erciyes Üniversitesi Adresli: Evet

Özet

BackgroundBlood neutrophil-to-lymphocyte (N/L) ratio is an indicator of the overall inflammatory status of the body, and an alteration in N/L ratio may be found in ulcerative colitis (UC) patients. The aims of this study were to investigate the utility of N/L ratio as a simple and readily available predictor for clinical disease activity in UC. J. Clin. Lab. Anal. 27:72-76, 2013. (c) 2012 Wiley Periodicals, Inc.
BACKGROUND: Blood neutrophil-to-lymphocyte (N/L) ratio is an indicator of the overall inflammatory status of the body, and an alteration in N/L ratio may be found in ulcerative colitis (UC) patients. The aims of this study were to investigate the utility of N/L ratio as a simple and readily available predictor for clinical disease activity in UC. METHODS: Twenty-six patients and 28 healthy controls were enrolled in the study. The neutrophil and lymphocyte counts were recorded, and the N/L ratio was calculated from these parameters. The extent of disease classified according to the Montreal classification, clinical disease activity was evaluated using a modified Truelove-Witts severity index, and endoscopic disease activities were classified according to Schroder et al. RESULTS: The serum N/L ratios of active patients were significantly higher than those of inactive UC and controls (P < 0.001). The optimum N/L ratio cut-off point for active UC was 2.47. There was no significant difference between inflammation parameters, disease extension, and disease activity. CONCLUSION: Our results demonstrate that N/L ratio is higher in patients with active UC compared with controls and UC patients in remission and a cut-off value of 2.47 can be used to identify patients with active ulcerative colitis.